Based on usability, the reusable segment accounted for over 23% share of the personal protective equipment for infection control market in 2022, considering the product’s high sustainability and affordability. The increasing awareness about the generation of single-use gown waste and its contribution to the medical waste disposal issue has grown, resulting in a shift toward reusable counterparts. Since waste management has become a major concern for healthcare facilities, the adoption of reusable personal protective equipment in hospitals is expected to rise considerably in the upcoming years.

Personal protective equipment for infection control market from the research and diagnostic laboratories segment will reach over USD 5 billion by 2032, given the increase in clinical research funding. For instance, in November 2022, Tennessee-based Oak Ridge National Laboratory received funding worth USD 497 million under the Inflation Reduction Act signed into law in August. This funding was intended for scientific research and other programs, thus bolstering the usage of PPE to reduce infections. Furthermore, the need to improve infectious disease diagnosis will bolster the use of personal protective equipment for infection control in research and diagnostic labs.

Europe personal protective equipment for infection control market size is expected to be worth over USD 6 billion by 2032, on account of the increasing incidence of infectious diseases. This growing burden of infectious diseases and the escalating R&D efforts toward the development of advanced treatments will amplify the production of PPE for infection control across the region.